Mar 1, 1975

Rosette formation by mouse lymphocytes. IV. Fc and C3 receptors occurring together and separately on T cells and other leucocytes

Clinical and Experimental Immunology
M I GyöngyössyJ H Playfair

Abstract

A method is described for detecting the simultaneous presence of Fc and C3 receptors on mouse spleen cells. A proportion of both T cells and non-T cells bear both receptors. Both T-cell and non-T-cell Fc receptors were blocked by aggregated mouse IgG2 to the same degree. C3, but not Fc, receptors were blocked by factors present in the serum of irradiated mice or mice undergoing graft-versus-host reaction. Thymocytes activated by injection into irradiated F1 hybrid mice, and thymocytes regenerating after irradiation and bone marrow injection, appeared to have increased Fc receptors. A general role for Fc and C3 receptors in T cell-B cell co-operation is suggested.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Immunofluorescence Assay
T-Lymphocyte
Spleen
Lymphocytes as Percentage of Blood Leukocytes (Lab Test)
Complement C3 precursor
IgG2
Aggregation
Bone Marrow
Lymphoid Cells
Thymocyte

About this Paper

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.